Billionaire Carl Icahn Increases Exposure to AIG, Xerox; Dumps Gannett, Hologic

Icahn Sold Out Entire Gannett Co Inc. (NYSE:GCI) Position

– Number of shares owned by Carl Icahn as of March 31: 0

– Value of Carl Icahn’s holding as of March 31: 0

Carl Icahn sold out his entire 6.50 million-share position in Gannett Co Inc. (NYSE:GCI) during the March quarter. The multi-platform news and information company has seen its market drop nearly 2% since the beginning of 2016. Gannett, the publisher of USA TODAY, recently approached Tribune Publishing Co (NYSE:TPUB), the owner of the Los Angeles Times and Chicago Tribune, with an unsolicited offer of $12.25 per share, but the target rejected the offer. However, Gannett is not giving up just yet, as the international news and information company boosted its offer to $15.00 per share, which values Tribune at approximately $475 million. The bidder’s operations include 112 daily publications and related digital platforms in the United States and the United Kingdom, as well as more than 400 non-daily local publications in the U.S. and more than 150 such publications in the U.K. Howard Guberman’s Gruss Asset Management added a 653,000-share position in Gannett Co Inc. (NYSE:GCI) to its pool of holdings during the first quarter of 2016.

Icahn Exits Successful Activist Campaign on Hologic Inc. (NASDAQ:HOLX)

– Number of shares owned by Carl Icahn as of March 31: 0

– Value of Carl Icahn’s holding as of March 31: 0

The billionaire investor also jettisoned his 28.15 million-share position in Hologic Inc. (NASDAQ:HOLX) during the first three months of 2016. Mr. Icahn disclosed a double-digit equity stake in the medical product company in late 2013 and then landed two seats on the company’s Board of Directors. The activist investor also maneuvered the appointment of Stephen P. MacMillan as Chief Executive Officer in December of 2013 to replace former CEO, Jack W. Cumming. Earlier this year, the activist investor said that his investment in Hologic serves as “the quintessential example of activism at its best”, thanking Mr. MacMillan for “a job well done”. Although the medical-equipment maker continues to grow at a solid pace, the management’s revenue guidance for the third quarter of fiscal 2016 didn’t seem to please investors. Hologic shares are down 11% year-to-date. Israel Englander’s Millennium Management reported ownership of 3.20 million shares of Hologic Inc. (NASDAQ:HOLX) through the latest round of 13Fs.

Disclosure: None